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lthough an excess of reactive oxygen species
(ROS) can damage the vasculature, low concen-
trations of ROS mediate intracellular signal
transduction pathways. We hypothesized that hydrogen
peroxide plays a beneﬁcial role in the vasculature by
inhibiting endothelial exocytosis that would otherwise
induce vascular inﬂammation and thrombosis. We now
show that endogenous H
 
2
 
O
 
2
 
 inhibits thrombin-induced
exocytosis of granules from endothelial cells. H
 
2
 
O
 
2
 
 regu-
lates exocytosis by inhibiting 
 
N
 
-ethylmaleimide sensitive
factor (NSF), a protein that regulates membrane fusion
A
 
events necessary for exocytosis. H
 
2
 
O
 
2
 
 decreases the abil-
ity of NSF to hydrolyze adenosine triphosphate and to
disassemble the soluble NSF attachment protein receptor
complex. Mutation of NSF cysteine residue C264T elimi-
nates the sensitivity of NSF to H
 
2
 
O
 
2
 
, suggesting that this
cysteine residue is a redox sensor for NSF. Increasing en-
dogenous H
 
2
 
O
 
2
 
 levels in mice decreases exocytosis and
platelet rolling on venules in vivo. By inhibiting endothe-
lial cell exocytosis, endogenous H
 
2
 
O
 
2
 
 may protect the
vasculature from inﬂammation and thrombosis.
 
Introduction
 
Reactive oxygen species (ROS) play a critical role in vascu-
lar signaling, mediating cellular responses to ligands such as
growth factors and cytokines (Finkel and Holbrook, 2000;
Griendling et al., 2000; Xu et al., 2002). Elevated levels of
ROS that are associated with cardiovascular diseases such as
diabetes, hypertension, and atherosclerosis promote vascular
inflammation by modulating proinflammatory transcription
factors, by oxidizing LDL, and by limiting the bioavailability
of nitric oxide (NO; Griendling and Alexander, 1997; Maytin
et al., 1999; Harrison et al., 2003; Nedeljkovic et al., 2003).
However, low levels of ROS play a physiological role by act-
ing as second messengers (Goldschmidt-Clermont and Moldo-
van, 1999; Griendling and Harrison, 1999; Cai and Harrison,
2000; Finkel, 2000). Extracellular ligands activate produc-
tion of intracellular ROS, which modulate specific signal
transduction pathways (Sundaresan et al., 1995; Bae et al.,
1997; Hampton and Orrenius, 1997; Irani et al., 1997; Ushio-
Fukai et al., 1998; Goldhaber and Qayyum, 2000; Irani,
2000; Hara et al., 2002; Liu and Gutterman, 2002; Meng et
al., 2002). Low concentrations of ROS may protect the vas-
culature from inflammation.
Weibel-Palade body exocytosis is one mechanism by
which endothelial cells promote vascular inflammation (Wei-
bel and Palade, 1964; Wagner, 1993). Weibel-Palade bodies
are endothelial cell granules that contain von Willebrand’s fac-
tor (vWF) and P-selectin (Wagner et al., 1982; Larsen et al.,
1989; McEver et al., 1989; Vischer and Wagner, 1993). A variety
of proinflammatory agonists trigger endothelial cell exocytosis of
Weibel-Palade bodies, releasing vWF into the lumen, which
promotes platelet adhesion and aggregation, and translocates
P-selectin to the luminal surface, which facilitates leukocyte
rolling. Weibel-Palade body exocytosis is regulated by members
of the SNARE superfamily and NSF (Jahn and Sudhof, 1999;
Mellman and Warren, 2000; Sollner, 2003). We recently discov-
ered that NO regulates exocytosis by 
 
S
 
-nitrosylating cysteine
residues on NSF (Matsushita et al., 2003). Because low levels
of ROS may protect the vasculature from inflammation, we hy-
pothesized that hydrogen peroxide modulates exocytosis by
regulating NSF.
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Results
 
To explore the effect of H
 
2
 
O
 
2
 
 on granule exocytosis, we studied
thrombin-induced exocytosis of Weibel-Palade bodies from hu-
man aortic endothelial cells (HAEC). We pretreated HAEC with
H
 
2
 
O
 
2
 
 for 10 min, and then stimulated the cells with thrombin, and
measured the amount of vWF released into the media. Thrombin
induces the rapid release of vWF from HAEC (Fig. 1, A and B).
However, exogenous H
 
2
 
O
 
2
 
 blocks the effects of thrombin in a
dose-dependent manner (Fig. 1, A and B). We next examined the
effect of the antioxidant 
 
N
 
-acetyl-cysteine (NAC) on Weibel-
Palade body exocytosis. HAEC were incubated with NAC for
4 h, washed, treated with H
 
2
 
O
 
2
 
, and finally stimulated with media
or thrombin, and exocytosis was measured with an ELISA for
vWF. NAC counteracts the inhibitory effect of H
 
2
 
O
 
2
 
 (Fig. 1 C).
 
Endogenous H
 
2
 
O
 
2
 
 inhibits exocytosis
 
We next examined the role of endogenous H
 
2
 
O
 
2
 
 in the regula-
tion of Weibel-Palade body exocytosis. First, we showed that
thrombin increases endogenous H
 
2
 
O
 
2
 
 production. We trans-
duced HAEC with adenoviral vectors expressing 
 
 
 
-galactosi-
dase or catalase and measured cellular levels of H
 
2
 
O
 
2
 
 before
and after thrombin treatment. Thrombin increases endogenous
H
 
2
 
O
 
2
 
 production in control cells, but transduction with aden-
ovirus-catalase blocks thrombin stimulation of endogenous
H
 
2
 
O
 
2
 
 production (Fig. 2 A). These data suggest that thrombin
activates endogenous H
 
2
 
O
 
2
 
 production and catalase decreases
endogenous H
 
2
 
O
 
2
 
 levels.
We used these adenoviral vectors to determine the effect of
endogenous H
 
2
 
O
 
2
 
 on Weibel-Palade body exocytosis. Thrombin
stimulates control HAEC to release vWF (Fig. 2 B). Expression
of 
 
 
 
-galactosidase has no effect on vWF release. However, ex-
pression of catalase increases vWF release from resting cells and
from thrombin-stimulated cells (Fig. 2 B). Furthermore, expres-
sion of superoxide dismutase (SOD) decreases the release of vWF
(Fig. 2 B). These data suggest that endogenous H
 
2
 
O
 
2
 
 produced in
response to thrombin inhibits Weibel-Palade body exocytosis.
We next pretreated HAEC with angiotensin II to activate
endogenous production of H
 
2
 
O
 
2
 
 (Ku et al., 1993; Papa-
petropoulos et al., 1997; Dimmeler et al., 1999; Fulton et al.,
1999). Treatment with 10
 
 
 
7
 
 M angiotensin II for 30 min de-
creases thrombin-stimulated vWF release (Fig. 2 C). Catalase
or an angiotensin II antagonist peptide blocks the effects of an-
giotensin II treatment, implying that H
 
2
 
O
 
2
 
 mediates angiotensin
II inhibition of exocytosis (Fig. 2 C). These data suggest that
endogenous H
 
2
 
O
 
2
 
 regulates endothelial cell exocytosis.
 
H
 
2
 
O
 
2
 
 inhibits NSF
 
How does H
 
2
 
O
 
2
 
 inhibit exocytosis? We hypothesized that H
 
2
 
O
 
2
 
inhibits NSF, a protein that regulates granule exocytosis, by
Figure 1. Exogenous H2O2 inhibits exocytosis from HAEC. (A) Dose re-
sponse. HAEC were pretreated with increasing amounts of exogenous
H2O2 for 10 min, and then treated with 1 U/ml thrombin, and the amount
of vWF released into the media was measured by an ELISA (n   3   SD;
*, P   0.05 vs. thrombin; **, P   0.01 vs. thrombin). (B) Time course.
HAEC were pretreated with exogenous H2O2 for 10 min, and then treated
with 1 U/ml thrombin, and the amount of vWF released into the media at
increasing times was measured by an ELISA (n   3   SD). (C) NAC de-
creases exogenous H2O2 inhibition of thrombin-triggered vWF release.
Cells were incubated with 10 mM NAC for 4 h, washed, treated with
H2O2, and stimulated with media or thrombin, and the amount of released
vWF was measured (n   3   SD; **, P   0.01 vs. H2O2 alone).
Figure 2. Endogenous H2O2 inhibits exocytosis from HAEC. (A) Catalase
inhibits endogenous H2O2 production. HAEC were transduced with adeno-
viral vectors and stimulated with thrombin. The amount of H2O2 released
from cells was measured by monitoring the increase in fluorescence of
N-acetyl-3,7-dihydroxyphenoxazine (n   3   SD; **, P   0.01 vs.
control). (B) Endogenous H2O2 decreases thrombin-triggered vWF release.
HAEC were transduced with adenoviral vectors and, after 48 h, treated
with thrombin, and vWF was measured with an ELISA (n   3   SD; **,
P   0.01 vs. none). (C) Angiotensin II induction of endogenous H2O2
decreases vWF release. HAEC were stimulated with 10
 7 M angiotensin
II for 30 min, and then incubated with thrombin and 500 U/ml catalase
or 10 mM angiotensin II antipeptide. The amount of vWF released from
cells into the media was measured by an ELISA (n   3   SD; **, P  
0.01 vs. control).HYDROGEN PEROXIDE REGULATION OF EXOCYTOSIS • MATSUSHITA ET AL. 75
hydrolyzing ATP and by interacting with SNARE molecules
(Block et al., 1988; Malhotra et al., 1988; Mellman and Warren,
2000). We first examined the effect of H2O2 on the ATPase ac-
tivity of NSF, which is critical for NSF function (Whiteheart
et al., 1994). H2O2 was added to 10  g of recombinant NSF,
and the ATPase activity of NSF was measured by a colori-
metric assay. H2O2 significantly inhibits NSF hydrolysis of
ATP (Fig. 3 A).
If H2O2 reversibly oxidizes NSF cysteine residues, then
the reducing agent DTT would be predicted to reduce oxidized
cysteine residues and restore NSF ATPase activity. To test this
prediction, we treated recombinant NSF with H2O2, added
DTT, and measured the ATPase activity of NSF. H2O2 inhibits
NSF ATPase activity, and DTT restores ATPase activity of
NSF exposed to H2O2 (Fig. 3 B).
We next explored the effect of H2O2 on NSF disassembly
activity. NSF interacts with SNARE molecules using  -SNAP
as an adaptor (Jahn and Sudhof, 1999; Mellman and Warren,
2000). ATP- S locks NSF onto the SNARE complex; how-
ever, ATP enables NSF to separate from and disassemble the
SNARE complex. Accordingly, we examined the effect of
H2O2 on NSF disassembly of recombinant SNARE molecules.
Recombinant (His)6-NSF was pretreated or not with H2O2.
Then, (His)6-NSF and (His)6- -SNAP were incubated with re-
combinant SNARE polypeptides that regulate Weibel-Palade
body exocytosis: GST-syntaxin-4 as well as nontagged VAMP-3
and SNAP-23. ATP or ATP- S was added to the mixture, the
mixture was precipitated with glutathione-sepharose beads,
and precipitated proteins were fractionated by SDS-PAGE and
immunoblotted with antibody to the NSF tag, syntaxin, and
VAMP-3.
ATP- S increases the interaction of NSF with SNARE
polypeptides. ATP decreases the interaction of NSF with
SNARE polypeptides (Fig. 3 C). However, H2O2 blocks NSF
disassembly of the SNARE complex in the presence of ATP
(Fig. 3 C). H2O2 inhibits disassembly activity of wild-type NSF
in a dose-dependent manner (Fig. 3 D). Together, these data
show that H2O2 blocks NSF disassembly activity.
We next confirmed that NSF is an intracellular target of
H2O2. We treated HAEC with H2O2, and then permeabilized
the cells and added recombinant NSF. H2O2 blocks exocytosis
as before (Fig. 3 E). Recombinant NSF restores exocytosis to
cells inhibited with H2O2 (Fig. 3 E). Furthermore, oxidized
NSF cannot restore exocytosis to HAEC (Fig. 3 E). As an addi-
tional control, we added to HAEC either wild-type NSF or a
mutant NSF(C264A) with decreased ATPase activity. Although
wild-type NSF restores secretion to endothelial cells, the kinase-
dead mutant NSF does not (Fig. 3 F). These data demonstrate
that NSF is an intracellular target of H2O2.
Specific cysteine residues mediate NSF 
sensitivity to H2O2
H2O2 may regulate NSF by oxidizing cysteine residues. To de-
termine which of the nine cysteine residues of NSF are targets
of H2O2, we expressed in bacteria and purified wild-type or mu-
tant NSF polypeptides with each of the nine individual cysteine
residues of NSF replaced by Ala. We added H2O2 to wild-type
and mutant NSF polypeptides and measured ATPase activity.
Mutation of cysteine residues 21, 91, 264, and 334 decreases
NSF ATPase activity (Fig. 4 A). H2O2 treatment inhibits ATP-
ase activity of all mutant NSF except mutants C21A and C264A
(Fig. 4 A). These data suggest that cysteine residues C21 and
C264 mediate H2O2 inhibition of NSF ATPase activity.
We next determined which cysteine residues mediate
H2O2 inhibition of NSF separation from the SNARE complex.
Figure 3. H2O2 inhibits NSF. (A) H2O2 inhibits ATPase activity of wild-
type NSF. H2O2 or control was added to recombinant wild-type NSF, and
the ATPase activity of NSF was measured (n   2   SD; *, P   0.05 vs.
NSF; **, P   0.01 vs. NSF). (B) DTT restores ATPase activity of wild-type
NSF inhibited by H2O2. H2O2 or control was added to recombinant wild-
type NSF, buffer or 1 mM DTT was added, and the ATPase activity of NSF
was measured (n   3   SD; *, P   0.01 for H2O2 vs. H2O2   DTT).
(C) H2O2 inhibits disassembly activity of wild-type NSF. Recombinant
(His)6-NSF was pretreated or not with 1 mM H2O2 and incubated with
(His)6- -SNAP, GST-Syntaxin-4, VAMP-3, and SNAP-23. ATP or ATP- S
was added, and the mixture was precipitated with glutathione-sepharose.
Precipitated proteins were immunoblotted with antibody to the NSF tag
(top), to syntaxin-4 (middle), or to VAMP-3 (bottom). Experiment was re-
peated three times with similar results. (D) H2O2 inhibits disassembly activity
of wild-type NSF (dose response). The NSF disassembly assay was per-
formed, pretreating recombinant (His)6-NSF with increasing concentra-
tions of H2O2  and then mixing with (His)6- -SNAP, GST-Syntaxin-4,
VAMP-3, and SNAP-23. Proteins precipitated with glutathione-sepharose
were immunoblotted with antibody to the NSF tag (top), to syntaxin-4
(middle), or to VAMP-3 (bottom). Experiment was repeated three times
with similar results. (E) Exogenous NSF restores vWF exocytosis in endo-
thelial cells treated with H2O2. HAEC were pretreated with 1 mM H2O2
for 10 min, permeabilized with SLO, incubated with recombinant NSF or
H2O2-treated recombinant NSF, and stimulated with thrombin, and the
amount of vWF in the media was measured (n   3   SD; *, P   0.01 for
H2O2 vs. H2O2   NSF). (F) NSF mutant C264A does not restore exocy-
tosis. HAEC were pretreated with 1 mM H2O2 for 10 min, permeabil-
ized,  and incubated with recombinant wild-type NSF (WT) or mutant
NSF(C264A). In some cases, the recombinant NSF was treated with H2O2
before addition to cells. The cells were then resealed and stimulated with
thrombin, and the amount of vWF in the media was measured (n   3   SD;
*, P   0.01 vs. H2O2   Thrombin).JCB • VOLUME 170 • NUMBER 1 • 2005 76
We used the NSF-SNARE pull-down assay, adding H2O2 to
NSF mutants lacking individual cysteine residues, along with
 -SNAP, GST-syntaxin-4, VAMP-3, and SNAP-23. H2O2
blocks the ability of wild-type NSF to separate from the
SNARE complex in the presence of ATP (Fig. 4 B). Mutation
of cysteine residues 250 and 599 has no effect on the ability of
H2O2 to inhibit NSF separation from the SNARE complex. The
effect of H2O2 on cysteine residues 11, 21, 334, 568, and 582
cannot be ascertained because mutation of these residues abro-
gates NSF interaction with SNARE molecules. Mutation of
cysteine residues 91 and 264 blocks the ability of NSF to sepa-
rate from the SNARE complex, and H2O2 has no effect on
these mutants. These data exclude cysteine residues C250 and
C599 as targets of H2O2, and the data indirectly suggest that
cysteine residues C91 and C264 may mediate H2O2 inhibition
of NSF separation from the SNARE complex.
To explore the physical effects of H2O2 on NSF, we ex-
posed recombinant wild-type and mutant NSF to H2O2, fraction-
ated the NSF by nondenaturing PAGE, and then immunoblotted
with antibody to NSF. Wild-type NSF runs as two bands, a
darker band at  70 kD and a fainter band at  85 kD (Fig. 4 C).
H2O2 changes the mobility of wild-type NSF, generating a dou-
blet of decreased mobility (Fig. 4 C). We next determined
which cysteine residues mediate the shift in mobility induced
by H2O2. We treated mutant NSF with H2O2 and then examined
the mobility on nondenaturing PAGE. Oxidant stress causes a
slight decrease in mobility of NSF(C11A) and NSF(C21A). In
contrast, H2O2 does not change the mobility of NSF(C264A)
(Fig. 4 C). These data suggest that H2O2 alters the physical
properties of NSF and that C264 mediates some of the physical
effects of H2O2 on NSF.
Mutant NSF(C264T) is resistant to 
H2O2
We next constructed a H2O2-resistant NSF mutant and used it
to make an endothelial cell line containing H2O2-resistant NSF.
Our data suggested that C264 may be a redox-sensitive cys-
teine residue in NSF. A comparison of primary NSF amino
acid sequences reveals that C264 in the Walker A box of the
D1 domain of NSF may be a recent evolutionary adaptation
(Sollner and Sequeira, 2003). The amino acid residue in this
position is cysteine in vertebrates but is threonine in insects,
plants, and yeast (Sollner and Sequeira, 2003). We hypothe-
Figure 4. NSF cysteine residue targets of H2O2. (A) Specific NSF mutants
are resistant to H2O2 inhibition of ATPase activity. 1 mM H2O2 or control
was added to recombinant wild-type and mutant NSF, and the ATPase ac-
tivity was measured. H2O2 inhibits ATPase activity of wild-type NSF and
all mutant NSF, except for C21A and C264A mutants (n   2   SD; **,
P   0.01 vs. control). (B) H2O2 does not affect interaction of specific NSF
mutants with syntaxin-4. (His)6-NSF was pretreated or not with 1 mM
H2O2, and then mixed with (His)6- -SNAP, GST-Syntaxin-4, VAMP-3, and
SNAP-23. The mixture was precipitated with glutathione-sepharose and
immunoblotted with antibody to NSF. (C) H2O2 alters the mobility of NSF
mutants. Recombinant wild-type or mutant NSF was treated with 0.1 mM
H2O2 for 5 min, fractionated by nondenaturing PAGE, and then immuno-
blotted with antibody to NSF.
Figure 5. Mutant NSF(C264T) is resistant to H2O2. (A) H2O2 does not affect
ATPase activity of mutant NSF(C264T). The ATPase assay was performed,
adding recombinant wild-type or mutant NSF. 100  M H2O2 inhibits ATP-
ase activity of wild-type NSF but not of mutant NSF(C264T). H2O2 has no
effect on ATPase activity of NSF(C264A) (n   3   SD; **, P   0.01 vs.
control). (B) H2O2 does not affect disassembly activity of specific NSF
mutants. The disassembly assay was performed, adding  -SNAP, GST-
Syntaxin-4, VAMP-3, SNAP-23, and recombinant wild-type NSF (WT) or
mutant NSF(C264A) or NSF(C264T). Precipitated proteins were immuno-
blotted with antibody to the NSF tag (top), to syntaxin-4 (middle), or to
VAMP-3 (bottom). Experiment was repeated three times with similar results.
1 mM H2O2 inhibits disassembly activity of wild-type NSF but not of mutant
NSF(C264T). (C) H2O2 does not affect exocytosis in endothelial cells con-
taining NSF mutants. HAEC were permeabilized with SLO and incubated
with recombinant wild-type NSF or mutant NSF(C264T). Cells were re-
sealed, pretreated with 0 or 100  M H2O2 for 10 min, and treated with
thrombin. The amount of vWF released into the media was measured by
an ELISA (n   3   SD; *, P   0.01 for thrombin vs. thrombin   H2O2).HYDROGEN PEROXIDE REGULATION OF EXOCYTOSIS • MATSUSHITA ET AL. 77
sized that a mutant NSF(C264T) would retain NSF activity but
would be resistant to H2O2. To test this idea, we constructed the
NSF mutant NSF(C264T).
We first compared the effect of H2O2 on the ATPase ac-
tivity of recombinant wild-type NSF and mutant NSF(C264T).
The ATPase activity of the NSF(C264T) mutant is approxi-
mately the same as that of wild-type NSF, although the ATPase
activity of mutant NSF(C264A) is greatly decreased (Fig. 5 A).
H2O2 inhibits ATPase activity of wild-type NSF but not of mu-
tant NSF(C264T) (Fig. 5 A).
We next compared the effect of H2O2 on the disassembly
activity of wild-type NSF and mutant NSF(C264T). The disas-
sembly activity of the NSF(C264T) mutant is similar to that of
the wild-type NSF (Fig. 5 B). H2O2 inhibits disassembly activ-
ity of wild-type NSF but not of mutant NSF(C264T) (Fig. 5 B).
We then constructed endothelial cells that contain the
NSF(C264T) mutant. Endothelial cells were permeabilized
with SLO and then incubated with wild-type or mutant NSF.
Thrombin activates exocytosis in HAEC containing wild-type
NSF and mutant NSF(C264T) (Fig. 5 C). H2O2 inhibits exocy-
tosis from cells containing wild-type NSF. In contrast, H2O2
does not affect exocytosis from endothelial cells containing
NSF(C264T) (Fig. 5 C). Together, these data show that NSF
residue C264 is a target of H2O2. These data also support the
hypothesis that H2O2 inhibits exocytosis by oxidation of NSF.
H2O2 inhibits exocytosis in vivo
We also examined the physiological effects of H2O2 on exocy-
tosis in vivo. If H2O2 inhibits exocytosis, then we would expect
catalase inhibitors to increase endogenous H2O2 levels and to
decrease endothelial release of vWF. We first tested this hy-
pothesis in endothelial cells with the catalase inhibitor 3-amino-
triazole (3-AT). Increasing doses of 3-AT increase endothelial
levels of H2O2 (Fig. 6 A). Increasing doses of 3-AT also block
endothelial exocytosis (Fig. 6 B). We examined this phenome-
non in mice. We administered 3-AT to mice, and examined
H2O2 levels and exocytosis after 5 h. The catalase inhibitor
3-AT increases H2O2 levels in murine liver (Fig. 6 C). We exam-
ined the effect of 3-AT on platelet rolling along murine venules
stimulated with FeCl3; platelet rolling is mediated in part by
vWF released by endothelial exocytosis of Weibel-Palade bod-
ies (Andre et al., 2000). Mice were treated with 3-AT or PBS,
anesthetized, and injected with calcein-AM–labeled  platelets.
The mesentery was externalized, endothelial exocytosis was
induced by superfusing with FeCl3, and platelet rolling on
mesenteric venules was recorded using a digital fluorescent
camera. FeCl3 activates platelet rolling in control mice (Fig. 6,
D and E). However, 3-AT greatly inhibits FeCl3-activated
platelet rolling in mice (Fig. 6, D and E). Together, these data
suggest that H2O2 regulates endothelial exocytosis in vivo.
Discussion
The major finding of our study is that H2O2 regulates exocyto-
sis by inhibiting NSF. Construction of an H2O2-resistant mu-
tant NSF suggests that NSF residue C264 serves as a redox
sensor for NSF. These data extend our report that NO regulates
exocytosis by nitrosylating NSF (Matsushita et al., 2003). NO
and H2O2 appear to have distinct effects on NSF. Both NO and
H2O2 inhibit NSF disassembly activity, but only H2O2 inhibits
NSF ATPase activity. Together, our data suggest that the intra-
cellular redox state regulates exocytosis.
Thrombin not only stimulates endothelial exocytosis but
also stimulates H2O2 production, which inhibits exocytosis.
Other compounds that activate endothelial exocytosis also in-
crease H2O2 production, such as epinephrine, VEGF, and cer-
amide (Griendling and Alexander, 1997; Goldschmidt-Clermont
and Moldovan, 1999; Finkel, 2001). H2O2 may thus serve as a
negative feedback signal to regulate exocytosis. An imbalance in
oxidant stress (e.g., an increase in oxidants or a decrease in anti-
oxidant levels) would be predicted to decrease exocytosis, limit-
ing thrombosis and inflammation in the vasculature.
Several large randomized clinical trials have demon-
strated that antioxidants do not reduce mortality or cardiovas-
cular outcomes (Virtamo et al., 1998; Yusuf et al., 2000; de
Gaetano, 2001; Heart Protection Study Collaborative Group,
Figure 6. Hydrogen peroxide inhibits vWF release in vivo. (A) The cata-
lase inhibitor 3-AT increases H2O2 in cells. HAEC were pretreated with 3-AT
for 2 h. The amount of H2O2 released from cells was measured by moni-
toring the increase in fluorescence of N-acetyl-3,7-dihydroxyphenoxazine
(n   3   SD; *, P   0.01 vs. 0 mM). (B) The catalase inhibitor 3-AT de-
creases thrombin-induced exocytosis. HAEC were pretreated with 3-AT
for 2 h, and then incubated with thrombin for 1 h. The amount of vWF re-
leased from cells into the media was measured by an ELISA (n   3   SD;
*, P   0.01 vs. thrombin alone). (C) The catalase inhibitor 3-AT in-
creases H2O2 in mice. Mice were pretreated with 500 mg/kg 3-AT i.p.
After 5 h, the amount of H2O2 released from spleen homogenates was
measured by monitoring the increase in fluorescence of N-acetyl-3,7-dihy-
droxyphenoxazine (n   3   SD; *, P   0.01 vs. control). (D) The catalase
inhibitor 3-AT decreases platelet rolling in mice. Mice were pretreated or
not with 500 mg/kg 3-AT, and after 5 h the mice were anesthetized and
injected with calcein-AM–labeled platelets from nontreated mice. The mes-
entery was externalized, and 120–150- m-diam venules were treated
with 1 mM histamine. Platelet rolling on venules was imaged with a digi-
tal fluorescent camera (n   5–6   SEM). (E) Digital fluorescence images
of platelet rolling in mice treated with control or 3-AT (representative
images from n   5–6).JCB • VOLUME 170 • NUMBER 1 • 2005 78
2002; Morris and Carson, 2003). Our data suggest one explana-
tion for this lack of benefit: endogenous oxidants protect the
vasculature by inhibiting endothelial exocytosis that would
otherwise lead to vascular inflammation and thrombosis. Fu-
ture therapies aimed at modulating endogenous oxidants may
have to be narrowly tailored to block the harmful effects of rad-
icals while preserving the beneficial effects.
Materials and methods
Materials
Thrombin was purchased from Enzyme Research Laboratories. H2O2, cat-
alase, NAC, and angiotensin II were purchased from Sigma-Aldrich.
Mouse mAbs to NSF and syntaxin-4 were purchased from BD Biosciences.
The cDNA for GST-syntaxin-4, GST-SNAP-23, and GST-VAMP-3 were pro-
vided by J. Pevsner (Johns Hopkins University School of Medicine, Balti-
more, MD). The cDNAs of RGS-His6-NSF and RGS-His6- -SNAP were gifts
from J.E. Rothman (Rockefeller University, New York, NY).
Preparation of recombinant adenoviruses
The replication-deficient adenovirus encoding the epitope-tagged cata-
lase, SOD cDNA, and the adenovirus-LacZ were constructed by homolo-
gous recombination in 293 cells with use of the adenovirus-based plasmid
JM17 as previously described (Sundaresan et al., 1995; Irani et al.,
1997). All viruses were amplified and tittered in 293 cells and purified on
CsCl gradients.
Preparation of recombinant NSF and SNARE polypeptides
Mutation of the cysteine residues to alanine residues of NSF was per-
formed with a kit according to the manufacturer’s instructions (Stratagene).
Recombinant RGS-(His)6-NSF and RGS-(His)6- -SNAP were expressed in
bacteria and purified on a Ni-NTA-agarose column (HisTRAP; Amersham
Biosciences). Recombinant GST-SNARE proteins were expressed in BL21
cells and purified with glutathione-agarose (GSTrap; Amersham Bio-
sciences). For some assays, the GST tag was cleaved off of the GST-
SNARE polypeptides GST-VAMP-3 and GST-SNAP-23 with thrombin.
Cell culture and analysis of vWF release
HAEC were obtained from Clonetics and grown in EGM-2 media (Clonet-
ics). To measure the effect of H2O2 on vWF release, HAEC were pre-
treated with H2O2 for 10 min in the presence or absence of catalase. The
cells were washed and stimulated with 1 U/ml thrombin, and the amount
of vWF released into the media was measured by an ELISA (American Di-
agnostica, Inc.). To measure the effect of endogenous H2O2 on exocytosis,
HAEC were pretreated for 48 h with 200 MOI of adenovirus-catalase, ad-
enovirus-SOD, and adenovirus-LacZ before thrombin stimulation. As an al-
ternative approach, HAEC were pretreated with 10 mM NAC for 4 h,
washed with EGM-2 medium, and stimulated with 1 U/ml thrombin. The
supernatants were collected, and the concentration of vWF released into
the media was measured by an ELISA.
Permeabilization of HAEC
To determine the role of NSF and NSF mutants in Weibel-Palade body exo-
cytosis, HAEC were permeabilized, incubated with recombinant NSF or
NSF mutant polypeptides, and resealed. We developed a permeabilization
protocol specific for endothelial cells by following a method for optimization
of permeabilization with SLO (Walev et al., 2001). To permeabilize HAEC,
cells were grown in 96-well plates, washed with HBSS without Mg
2  and
Ca
2 , and incubated for 15 min at 37 C with 10 U SLO in 50  l PBS, pH
7.4, along with 100  g/ml NSF or NSF mutants. Cells were then resealed
by incubation with 250  l EGM-2 medium containing 2% FBS for 4 h at
37 C. The HAEC were then washed with EGM-2 medium and stimulated
with thrombin. The supernatants were collected and the concentration of
vWF released into the media was measured by an ELISA.
Endothelial H2O2 production
H2O2 was quantified using the Amplex Red Hydrogen Peroxide Assay
Kit (Molecular Probes) according to the manufacturer’s recommenda-
tions. The fluorescence of 10-acetyl-3,7-dihydroxyphenoxazine (Amplex
red reagent), a highly sensitive and stable probe for H2O2, was mea-
sured with a Cytofluor 2300 fluorimeter (Millipore; Mohanty et al.,
1997). Values represent the mean   SD from a representative experi-
ment that was repeated twice.
ATPase assay
The ATPase activity of NSF was measured by a coupled assay in which ATP
utilization is linked to the pyruvate kinase reaction, which generates pyru-
vate, which in turn is measured continuously with lactate dehydrogenase
(Huang and Hackney, 1994). Recombinant NSF (0.2  g/ l) was pre-
treated with buffer or H2O2 for 10 min at 22 C. ATPase reaction buffer
(100 mM Hepes buffer, pH 7.0, 100 mM KCl, 10 mM MgCl2, 5 mM
CaCl2, 10 mM ATP, 5 mM phosphoenol pyruvate, 50 U lactate dehydroge-
nase, and 50 U pyruvate kinase) was added to the mixture, followed by 10
 l of NADH (2 mg/ml in 1% sodium bicarbonate). The mixture was incu-
bated for 10 min at 22 C, and the absorbance was measured at 340 nm.
NSF disassembly assay
The disassembly activity of NSF was measured by a coprecipitation assay
as described previously (Pevsner et al., 1994; Matsushita et al., 2003).
Recombinant RGS-(His)6-NSF (0.1  g/ l) was pretreated with buffer or
H2O2 for 10 min at 22 C. Recombinant RGS-(His)6- -SNAP (0.1  g/ l)
and SNARE polypeptides (0.1  g/ l each of VAMP-3, SNAP-23, and
GST-Syntaxin-4) were added, followed by either 2.5 mM ATP/5 mM
MgCl2 or 2.5 mM ATP- S/5 mM MgCl2. This mixture of NSF and SNARE
polypeptides was then incubated in binding buffer (4 mM Hepes, pH 7.4,
0.1 M NaCl, 1 mM EDTA, 3.5 mM CaCl2, 3.5 mM MgCl2, and 0.5% NP-
40) and glutathione-sepharose beads for 1 h at 4 C with rotation. The
beads were washed with binding buffer four times, mixed with SDS-PAGE
sample buffer, boiled for 3 min, and analyzed by immunoblotting.
The ability of NSF to separate from SNARE polypeptides was mea-
sured using a similar assay. Recombinant RGS-(His)6-NSF was incubated
with recombinant RGS-(His)6- -SNAP (0.1  g/ l) and SNARE polypep-
tides (0.1  g/ l each of GST-Syntaxin-4, VAMP-3, and SNAP-23). The
GST-tagged syntaxin-4 fusion polypeptide was precipitated with glu-
tathione-sepharose beads, and the ability of NSF to separate from syn-
taxin-4 was measured by immunoblotting precipitants for NSF.
Intravital microscopy
Intravital microscopy was performed as has been previously described
(Andre et al., 2000). Platelets were isolated and purified from wild-type
C57BL6/J mice (The Jackson Laboratory) and incubated for 20 min with
1  M calcein-AM (Molecular Probes). Wild-type mice were pretreated
with saline or 3-AT for 5 h, anesthetized with ketamine (80 mg/kg) and
xylazine (13 mg/kg), and then injected i.v. with 5   10
7 platelets for the
rolling study or 10
8 platelets for the thrombosis study. The mesentery was
exteriorized and 120–150- m-diam venules were selected, and the
mouse mesentery was prepared on a stage heated to 37 C of an inverted
fluorescent microscope (model Eclipse TE200; Nikon). Endothelial dam-
age was induced by superfusion of 1 mM histamine, and images of plate-
let rolling were captured with a digital camera (Retiga Exi Fast1394;
QImaging) through a Modulation Optics objective lens with a 20  mag-
nification. The images were collected by QCapture PRO imaging software
(QImaging) and imported into Adobe Photoshop Creative Suites on an
Apple PowerPC G4 computer. Each image was adjusted with Adobe Pho-
toshop CS by selecting the entire image, opening the Levels dialogue box,
dragging the black Input Level slider to the leftmost cluster of pixels in the
histogram, and dragging the white Input Level slider to the rightmost clus-
ter of pixels in the histogram. Platelet rolling was determined by counting
the number of platelets that remained transiently within a frame for the 30-
ms collection time.
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